AA

Ashwani Anamisharan Khemka

Active Director Managing Director DIN 00337118
DIN 00337118 First appointment Jan 1991 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jan 1991
Shareholding value •••• Premium profile

About Ashwani Anamisharan Khemka

Data last updated:

Ashwani Anamisharan Khemka is a Managing Director at Sanjivani Paranteral Limited (since 1994), Director at Genesen Labs Limited (since 1991) and Director at Spl Infusion Private Limited (since 2024). The companies operate in Pharma and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹71.33 Cr; the largest is Sanjivani Paranteral Limited at ₹71.31 Cr (FY 2025). Earlier, Ashwani Anamisharan Khemka was a Director at Alfa Sales Private Limited (from 2001) and Director at Aagrah Properties Private Limited (from 2010).

DIN 00337118
Primary Designation Managing Director
Industry Pharma
First Appointment 04 Jan 1991
Oldest Company Age 44 yrs
Largest company Sanjivani Paranteral Limited · ₹71.31 Cr (FY 2025)
Combined revenue ₹71.33 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sanjivani Paranteral Limited L24300MH1994PLC081752
Managing Director05 Oct 19941994₹71.31 Cr (FY 2025)Active
Genesen Labs Limited U45200MH1982PLC027861
Director04 Jan 19911982₹1.5 Lakh (FY 2025)Active
Spl Infusion Private Limited U21001MH2024PTC419970
Director26 Feb 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alfa Sales Private Limited U25200MH2001PTC133275
Director05 Sep 20012001Strike Off
Aagrah Properties Private Limited U63011MH2000PTC129589
Director11 Feb 20102000Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sanjivani Paranteral Limited
Genesen Labs Limited
Alfa Sales Private Limited
Aagrah Properties Private Limited
Premium access

Shareholding and investment profile for Ashwani Anamisharan Khemka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwani Anamisharan Khemka

Ashwani Anamisharan Khemka currently holds 3 directorships: Sanjivani Paranteral Limited (Managing Director, since 05 Oct 1994, revenue ₹71.31 Cr (FY 2025)); Genesen Labs Limited (Director, since 04 Jan 1991, revenue ₹1.5 Lakh (FY 2025)); Spl Infusion Private Limited (Director, since 26 Feb 2024).

Ashwani Anamisharan Khemka was first appointed on 04 Jan 1991 as Director at Genesen Labs Limited. The most recent appointment on record is 26 Feb 2024 at Spl Infusion Private Limited.

The 2 current companies of Ashwani Anamisharan Khemka that report revenue have a combined latest revenue of ₹71.33 Cr: Sanjivani Paranteral Limited ₹71.31 Cr (FY 2025); Genesen Labs Limited ₹1.5 Lakh (FY 2025).

Ashwani Anamisharan Khemka held 2 earlier board appointments: Alfa Sales Private Limited (Director, from 05 Sep 2001); Aagrah Properties Private Limited (Director, from 11 Feb 2010).

The current boards of Ashwani Anamisharan Khemka's companies include Abhay Milan Shah (Sanjivani Paranteral Limited), Basant Shrivastava (Sanjivani Paranteral Limited), Monika Amit Singhania (Sanjivani Paranteral Limited), Pritesh Popatlal Jain (Sanjivani Paranteral Limited), Ravikumar Venkatramuloo Bogam (Sanjivani Paranteral Limited), Srivardhan Ashwani Khemka (Sanjivani Paranteral Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available